Phase II Study of Cetuximab Plus Concomitant Boost Radiotherapy in Japanese Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck

BACKGROUND: We investigated the tolerability of cetuximab plus radiotherapy in Japanese patients with untreated locally advanced squamous cell carcinoma of the head and neck. METHODS: Patients with epidermal growth factor receptor-expressing locally advanced squamous cell carcinoma of the head and n...

Descripción completa

Detalles Bibliográficos
Autores principales: Okano, Susumu, Yoshino, Takayuki, Fujii, Masato, Onozawa, Yusuke, Kodaira, Takeshi, Fujii, Hirofumi, Akimoto, Tetsuo, Ishikura, Satoshi, Oguchi, Masahiko, Zenda, Sadamoto, de Blas, Barbara, Tahara, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638633/
https://www.ncbi.nlm.nih.gov/pubmed/23479383
http://dx.doi.org/10.1093/jjco/hyt030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638633/
https://www.ncbi.nlm.nih.gov/pubmed/23479383
http://dx.doi.org/10.1093/jjco/hyt030

Ejemplares similares